NM_001759.4:c.570C>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001759.4(CCND2):​c.570C>G​(p.Thr190Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 1,608,466 control chromosomes in the GnomAD database, including 112,564 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8329 hom., cov: 33)
Exomes 𝑓: 0.37 ( 104235 hom. )

Consequence

CCND2
NM_001759.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0001498
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.104

Publications

31 publications found
Variant links:
Genes affected
CCND2 (HGNC:1583): (cyclin D2) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]
CCND2 Gene-Disease associations (from GenCC):
  • megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.016).
BP6
Variant 12-4278918-C-G is Benign according to our data. Variant chr12-4278918-C-G is described in ClinVar as Benign. ClinVar VariationId is 380772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.104 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCND2NM_001759.4 linkc.570C>G p.Thr190Thr splice_region_variant, synonymous_variant Exon 3 of 5 ENST00000261254.8 NP_001750.1 P30279-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCND2ENST00000261254.8 linkc.570C>G p.Thr190Thr splice_region_variant, synonymous_variant Exon 3 of 5 1 NM_001759.4 ENSP00000261254.3 P30279-1
ENSG00000285901ENST00000674624.1 linkn.570C>G splice_region_variant, non_coding_transcript_exon_variant Exon 3 of 10 ENSP00000501898.1 A0A6Q8PFP0

Frequencies

GnomAD3 genomes
AF:
0.316
AC:
48009
AN:
151992
Hom.:
8334
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.429
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.425
Gnomad EAS
AF:
0.0868
Gnomad SAS
AF:
0.254
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.394
Gnomad OTH
AF:
0.334
GnomAD2 exomes
AF:
0.323
AC:
79825
AN:
246906
AF XY:
0.328
show subpopulations
Gnomad AFR exome
AF:
0.187
Gnomad AMR exome
AF:
0.299
Gnomad ASJ exome
AF:
0.417
Gnomad EAS exome
AF:
0.0777
Gnomad FIN exome
AF:
0.364
Gnomad NFE exome
AF:
0.391
Gnomad OTH exome
AF:
0.354
GnomAD4 exome
AF:
0.373
AC:
542798
AN:
1456356
Hom.:
104235
Cov.:
35
AF XY:
0.370
AC XY:
267958
AN XY:
723734
show subpopulations
African (AFR)
AF:
0.192
AC:
6423
AN:
33410
American (AMR)
AF:
0.302
AC:
13478
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.422
AC:
10998
AN:
26076
East Asian (EAS)
AF:
0.155
AC:
6143
AN:
39558
South Asian (SAS)
AF:
0.264
AC:
22764
AN:
86112
European-Finnish (FIN)
AF:
0.360
AC:
18846
AN:
52364
Middle Eastern (MID)
AF:
0.361
AC:
2078
AN:
5756
European-Non Finnish (NFE)
AF:
0.398
AC:
440919
AN:
1108314
Other (OTH)
AF:
0.352
AC:
21149
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
17021
34043
51064
68086
85107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13584
27168
40752
54336
67920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.316
AC:
48009
AN:
152110
Hom.:
8329
Cov.:
33
AF XY:
0.312
AC XY:
23211
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.198
AC:
8206
AN:
41502
American (AMR)
AF:
0.318
AC:
4870
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.425
AC:
1475
AN:
3472
East Asian (EAS)
AF:
0.0868
AC:
449
AN:
5174
South Asian (SAS)
AF:
0.255
AC:
1226
AN:
4812
European-Finnish (FIN)
AF:
0.365
AC:
3851
AN:
10552
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.393
AC:
26748
AN:
67986
Other (OTH)
AF:
0.329
AC:
695
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1668
3336
5004
6672
8340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
466
932
1398
1864
2330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.359
Hom.:
6675
Bravo
AF:
0.306
Asia WGS
AF:
0.133
AC:
466
AN:
3478
EpiCase
AF:
0.403
EpiControl
AF:
0.406

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.19
DANN
Benign
0.63
PhyloP100
-0.10
Mutation Taster
=75/25
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00015
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3217805; hg19: chr12-4388084; COSMIC: COSV54221448; COSMIC: COSV54221448; API